Cetirizine Impurity 17 HCl (Mixture of Cetirizine Impurity 9 HCl and Cetirizine Impurity 10 HCl)
-
Cetirizine Impurity 17 DiHCl (Mixture of Cetirizine Impurity 9 DiHCl and Cetirizine Impurity 10 DiHCl)
C-2071 | 100mg
-
Cetirizine Sorbitol Ester Impurity HCl (Mixture of Diastereomers)
C-2033 | 100mg
-
Cetirizine Impurity 15 DiHCl (Mixture of Cetirizine Impurity 11 DiHCl and Cetirizine Impurity 13 DiHCl)
C-2042 | 100mg
-
Cetirizine Impurity 16 DiHCl (Mixture of Cetirizine Impurity 12 DiHCl and Cetirizine Impurity 14 DiHCl)
C-2043 | 100mg
-
Cetirizine Glycerol Ester HCl (Mixture of Isomers)
C-2067 | 100mg
-
Cetirizine Impurity 10
C-2023 | 100mg
-
Cetirizine Impurity 9
C-2037 | 100mg
化合物名称：Cetirizine Impurity 17 HCl (Mixture of Cetirizine Impurity 9 HCl and Cetirizine Impurity 10 HCl)
同义词：1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl) piperazin-1-yl)ethoxy)acetate compound with 2-hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate, hydrochloride (1:1)
CAS 号：
其他 CAS 号：
分子式：C24H31ClN2O4. HCl
分子量：/
结构式图片：
您正在浏览的产品：Cetirizine Impurity 17 HCl (Mixture of Cetirizine Impurity 9 HCl and Cetirizine Impurity 10 HCl)
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。
2. 系统适用性测试需满足分离度（R≥1.5）和理论塔板数（≥2000）；
3. 进样体积20 μL，连续进样间隔需稳定基线；
4. 数据采集后需进行峰纯度分析（DAD检测）。
2. 实验过程中需避免强光直射样品溶液；
3. 若杂质峰与主峰未完全分离，需优化梯度程序或更换色谱柱。
以上信息仅供参考，请以相应标准的原文为准！